Research

Hormonal

Elevated local glucocorticoid activity in adipose tissue, driven by increased 11beta-HSD1 enzyme expression, causes visceral obesity and metabolic syndrome features despite normal circulating cortisol levels.

Visceral obesity is driven by local enzyme activity (11beta-HSD1) converting inactive steroids into active cortisol within belly fat, not necessarily by high blood cortisol. This suggests that therapies targeting this specific enzyme in adipose tissue could treat metabolic syndrome and visceral obesity without affecting systemic hormone levels.

GoodSupportsHIGH confidence
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), at least in mature adipocytes and hepatocytes, converts inactive circulating 11-keto steroids into active glucocorticoids, amplifying local glucocorticoid action. 11beta-HSD1 is elevated in adipose tissue in obese humans and rodents, suggesting that adipose tissue glucocorticoid excess may explain the conundrum.
Jonathan R. Seckl · Recent Progress in Hormone Research · 2004

Why this rating

Supported by multiple lines of evidence including human observational studies, transgenic mouse models (overexpression and knockout), and biochemical assays.

Source

Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue

Jonathan R. Seckl · Recent Progress in Hormone Research · 2004

DOI 10.1210/rp.59.1.359

narrative_reviewCited 235×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →